Racial, Ethnic, Economic Disparities Identified in Adoption of PCI Services

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, July 9, 2024 -- Hospitals serving communities with large proportions of Black and Hispanic residents and with residential segregation are less likely to adopt percutaneous coronary intervention (PCI) services, according to a study published in the July issue of Health Affairs.

Renee Y. Hsia, M.D., from the University of California San Francisco, and Yu-Chu Shen, Ph.D., from the Naval Postgraduate School Monterey in California, examined PCI service adoption in U.S. general acute hospitals across communities during 2000 to 2020.

The researchers found that 1,621 of the 5,260 hospitals offered PCI services in 2020 or before, with 630 and 225 adding PCI services between 2001 and 2010 and between 2011 and 2020, respectively. Compared with hospitals serving non-Black, racially segregated communities, hospitals serving Black, racially segregated communities were 48 percent less likely to adopt PCI services, while adoption was 41 percent less likely for those serving Hispanic, ethnically segregated communities versus those serving non-Hispanic, ethnically segregated communities. The likelihood of adopting PCI services was 1.8 times higher for hospitals in high-income economically integrated communities versus those in high-income economically segregated communities; rural hospitals were more likely to adopt PCI services than urban hospitals.

"Successful policy interventions addressing the observed disparities in service adoption will rely on a thorough understanding of where PCI services currently exist and where they are expanding in relation to community needs," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords